- Global Pharma News & Resources

Bioprocess Integrity Testing Systems Market is expected to grow at a CAGR of 5.7% to be valued at US$ 136.6 Million by 2032

The global Bioprocess Integrity Testing Systems Market will be worth US$ 74.2 million in 2022, rising at a 5.7% CAGR to US$ 136.6 million between 2022 and 2032. Increased availability of fully automated integrity test solutions is related to growth. The biscuit mixes market grew at a CAGR of 5.0% between 2016 and 2021.

Bioprocess integrity testing systems are an efficient process to find errors that might be in the product owing to improper control and filling procedures. Bioprocess integrity testing systems allow users in the biopharmaceutical, and biotechnology industries to confirm the integrity of the product.

In the manufacturing of sterile drug products, it is critical to access filter integrity testing as regulated by regulatory bodies. The filter in the bioprocess is subjected to wear owing to particle load, fluctuations in pressure and temperature changes in pH, and other factors. The performance of filter elements is crucial in any bioprocess.

For More Insights on this Market, Get A Sample Report @

Bioprocess Integrity Testing Systems Market: Overview

In a process, a filter can have irreparable blockage of the filter membrane, cracks, and changes in the filter, with variations in the pore structure. Such blockages are easily detected cracks, however, variations in the pore are challenging to detect, and it is crucial to test the bioprocess integrity. Filter integrity testing varies from process to process such as for solutions it is preferred that the integrity test is performed during the final membrane filtration step and also before and after the use of filters in the process.

Bioprocess Integrity Testing Systems Market: Drivers and Restraints

Bioprocess integrity testing systems market would grow during the forecast years as many multi-national companies are focusing towards new product innovations and are required to follow the GMP guidelines which are the most critical factor in bioprocess integrity testing systems. Also, in the United States, there are stringent regulations for evaluation of materials and container closure systems the United States Pharmacopeia (USP) and Food and Drug Administration (FDA) have enforced stringent requirements for bioprocess integrity testing and Container Closure Integrity Testing (CCIT).

Have a Conversation with the Analyst @

Also, the integrity testing is highly recommended and adopted by leading biopharmaceutical players and biotechnology companies owing to the reliability of the systems, portability, and ease of implementation which is leading to a massive gain of market share in the bioprocess integrity testing systems market. Other factors contributing to bioprocess integrity testing systems market are increasing the availability of fully automated integrity test systems. The market for bioprocess integrity testing systems would be accelerated due to the accelerated testing capabilities of the systems.

Bioprocess Quality Assurance is used in the biopharmaceutical industry to ensure the quality and purity of biologics produced through bioprocessing. These systems are designed to detect any microbial contamination, impurities, or other irregularities that may compromise the quality and efficacy of the final product.

Bioprocess Integrity Testing Systems Market: Key Players

  • Merck Millipore
  • Eurofins Scientific
  • Pall Corporation
  • Sartorius Group
  • Viet Anh Scientific Co. Ltd.

To Buy this Report Visit @

Key Segments Profiled in the Bioprocess Integrity Testing System Industry Survey

Bioprocess Integrity Testing System Market by Product Type:

  • Bioprocess Integrity Destructive Testing System
  • Bioprocess Integrity Non-Destructive Testing System
  • Bioprocess Integrity Bubble Point Testing System
  • Bioprocess Integrity Diffusion Testing System
  • Bioprocess Integrity Pressure Hold Testing System

Bioprocess Integrity Testing System Market by Process Type:

  • Particle-based Bioprocess Integrity Testing System
  • Liquid Property Based Bioprocess Integrity Testing System

Bioprocess Integrity Testing System Market by End User:

  • Bioprocess Integrity Testing System for Biopharmaceutical Industry
  • Bioprocess Integrity Testing System for Biotechnology Industry
  • Bioprocess Integrity Testing System for Other End Users

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 21-Apr-2023